Codexis, Inc.
CDXS
Positions held
Your positionsCDXS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $148.93M | Enterprise value | $166.60M | Trailing P/E | — | Forward P/E | -4.25 |
| PEG | 13.53 | Price / book | 3.77 | Beta | 2.55 | Dividend yield | 0.00% |
| Revenue growth | -2.7% | Earnings growth | — | Gross margin | 24.3% | Operating margin | -75.3% |
| Profit margin | -39.6% | ROE | -69.4% | ROA | -11.7% | Debt / equity | 2.20 |
| Current ratio | 3.06 | Free cash flow | $2.13M | Analyst recommendation | buy | Mean target | $6.14 |
| 52w high | $2.98 | 52w low | $0.96 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $14.9M | $15.2M | $38.9M | $8.6M | $15.3M |
| Op margin | -75.3% | -52.7% | 35.9% | -220.3% | -83.9% |
| Net income | -$12.0M | -$8.7M | $9.6M | -$19.6M | -$13.3M |
| Gross margin | 76.5% | 86.5% | 94.8% | 71.3% | 86.3% |
| Gross profit | $11.4M | $13.2M | $36.9M | $6.1M | $13.2M |
| Operating income | -$11.2M | -$8.0M | $14.0M | -$18.9M | -$12.9M |
- Revenue -2% vs prior quarter ($15M vs $15M).
- Gross margin 76.5% (was 86.5% prior quarter).
- Operating margin compressed to -75.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $70.4M | $59.3M | $70.1M | $139M | — |
| Op margin | -54.5% | -98.3% | -78.1% | -22.9% | — |
| Net income | -$44.0M | -$65.3M | -$76.2M | -$33.6M | — |
| Gross margin | 86.7% | 72.6% | 81.7% | 72.6% | — |
| Gross profit | $61.0M | $43.1M | $57.3M | $101M | — |
| Operating income | -$38.3M | -$58.4M | -$54.8M | -$31.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-25 · What Needs To Be True To Buy Twist Bioscience Stock Now?
2026-08-27 · Codexis to Participate in Cantor Global Healthcare Conference 2026
2026-08-18 · Codexis (CDXS) Q2 2026 Earnings Call Transcript
2026-08-14 · Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
2026-08-12 · Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocatalysis Growth and ECO Synthesis ...
2026-08-12 · Codexis, Inc. Q2 2026 Earnings Call Summary
2026-08-11 · Codexis Q2 Earnings Call Highlights
2026-08-11 · Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
2026-08-11 · Codexis: Q2 Earnings Snapshot
2026-08-11 · Codexis Reports Second Quarter 2026 Financial Results
2026-08-03 · Codexis Appoints David Butler, PhD, to Strategic Advisory Board
Price (daily)
Full chart · RSI · MACD · patterns